In line with these results, Venneri et al. analyzed the frequency of TEMs in cancer specimens and found that 55 and 70% of CD14+ monocytes were TEMs in colorectal and lung carcinomas, respectively, [12]. This evidence concerns the gene CD14 and lung carcinoma.